mecamylamine has been researched along with Delayed Effects, Prenatal Exposure in 1 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, SP | 1 |
| Gundavarapu, S | 1 |
| Smith, KR | 1 |
| Chand, HS | 1 |
| Saeed, AI | 1 |
| Mishra, NC | 1 |
| Hutt, J | 1 |
| Barrett, EG | 1 |
| Husain, M | 1 |
| Harrod, KS | 1 |
| Langley, RJ | 1 |
| Sopori, ML | 1 |
1 other study available for mecamylamine and Delayed Effects, Prenatal Exposure
| Article | Year |
|---|---|
Gestational exposure of mice to secondhand cigarette smoke causes bronchopulmonary dysplasia blocked by the nicotinic receptor antagonist mecamylamine.
Topics: Air Pollutants; Animals; Bronchoalveolar Lavage Fluid; Bronchopulmonary Dysplasia; Female; Lung; Mec | 2013 |